Following the pilot program with international members - Australia, Canada, Japan and Brazil - the FDA has agreed to continue to accept MDSAP audit reports as a substitute for routine Agency inspections. This whitepaper details how your organisation can prepare for MDSAP, including:
- Major challenges
- An opportunity for quality
- Software solutions to streamline audit tasks
- ResMed - a successful case study
- The growing membership and benefits
To download simply log in or register for an Informa Connect account, which will give you access to all our exclusive premium content. Have any questions or interested in sponsoring future content? Email andrew.burrows@informa.com.